 |
|
Toxic epidermal necrolysis associated with deflazacort therapy with nephrotic syndrome
Eun Chae Lee, Geun A Kim, Ja Wook Koo
Kidney Res Clin Pract. 2014;33(4):222-225. Published online 2014 Nov 18 DOI: https://doi.org/10.1016/j.krcp.2014.08.002
|
|
Citations to this article as recorded by
 Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort: a case report and literature review
Min Song Jeong, Yun Young Choi, Yo Han Ahn, Kyeonghun Lee, Ji Soo Park, Dong In Suh
Frontiers in Immunology.2024;[Epub] CrossRef IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
Agnes Trautmann, Olivia Boyer, Elisabeth Hodson, Arvind Bagga, Debbie S. Gipson, Susan Samuel, Jack Wetzels, Khalid Alhasan, Sushmita Banerjee, Rajendra Bhimma, Melvin Bonilla-Felix, Francisco Cano, Martin Christian, Deirdre Hahn, Hee Gyung Kang, Koichi N
Pediatric Nephrology.2023; 38(3): 877. CrossRef Toxic epidermal necrolysis induced by deflazacort
Dail Youn, Min-Hye Kim, Seok Woong Koh, Jung Won Kim, Sang Eun Yoon, Hyeon Kyeong Jeon, Young-Joo Cho
Allergy, Asthma & Respiratory Disease.2016; 4(3): 221. CrossRef Two Cases of Toxic Epidermal Necrolysis Associated with Deflazacort Therapy in Nephrotic Syndrome: Successfully Treated with Cyclosporine A
Myung Hee Lim, Hee Jung Bae, Sun Young Park, Sae Yoon Kim, Yong Hoon Park
Childhood Kidney Diseases.2016; 20(2): 97. CrossRef Deflazacort/enalapril
Reactions Weekly.2015; 1535(1): 90. CrossRef
|